Good Afternoon,
Please see attached the CMS Memo regarding the revised Notice of Denial of Medicare Part D prescription drug coverage. The notices must be used no later than October 1, 2017.

The notices seem to be an improvement, including the requirement that, if a drug may be covered by Part B, the PDP plan has to highlight that fact and an MA-PD has to indicate that it was approved  under Medicare Part A or B.

The revised notices also includes the national toll-free number for the SHIP TA Center,

The English and Spanish notices, and instructions for their use, can be found here.  https://www.cms.gov/Medicare/Appeals-and-Grievances/MedPrescriptDrugApplGriev/PlanNoticesAndDocuments.html

Best,
Leslie

Leslie Fried, JD
Senior Director, Center for Benefits Access
Office: 571.527.3992
xxxxxx@ncoa.org

National Council on Aging
Improving the lives of millions of older adults
251 18th Street South, Suite 500
Arlington, VA 22202
ncoa.org | @NCOAging

-----Original Message-----
From: HPMS [mailto:xxxxxx@cms.hhs.gov]
Sent: Tuesday, August 01, 2017 6:20 PM
To: Leslie Fried <xxxxxx@ncoa.org>
Subject: Revised Notice of Denial of Medicare Part D Prescription Drug Coverage

Please see the attached memorandum entitled "Revised Notice of Denial of Medicare Part D Prescription Drug Coverage (CMS 10146)" from Jerry Mulcahy Director, Medicare Enrollment & Appeals Group.  The memorandum provides information regarding the availability of the revised Part D denial notice.

The information contained in this electronic mail and its attachments is privileged and confidential. It is intended for the use of the addressee and others specifically authorized to receive it. If you are not the intended recipient, you are prohibited from disseminating, distributing or copying this communication. If you have received this e-mail in error, please delete it and notify us by replying to this e-mail immediately.